TMC
FLGT icon

Trellus Management Company’s Fulgent Genetics FLGT Stock Holding History

Trellus Management Company’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.15M Buy
+43,100
New +$1.47M 1.58% 10

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Trellus Management Company's FLGT Position: Q3 2023 in Review

Trellus Management Company opened a new position in Fulgent Genetics (FLGT) in Q3 2023: 43,100 shares worth $1.15M. The stake represents 1.58% of the portfolio and ranks #10 among its holdings.

201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

  • Trellus Management Company held 43,100 shares of Fulgent Genetics worth $1.15M as of Q3 2023.
  • Fulgent Genetics was a new Trellus Management Company position in Q3 2023.
  • Fulgent Genetics made up 1.58% of Trellus Management Company's portfolio in Q3 2023, its #10 holding.
  • 201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on Trellus Management Company's 13F filing for Q3 2023, filed 24 Oct 2023.